Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07810205

Prospective Longitudinal Cohort Study of Implant Age, Pocket Plane, Incision, Surface Texture, and Volume as Predictors of Breast Implant Rupture

This prospective dynamic cohort will follow women with intact aesthetic silicone breast implants to evaluate predictors of rupture. Implant age, pocket plane, incision route, surface texture, and volume will be recorded, and participants will undergo annual clinical and imaging surveillance for up to five years. Confirmed rupture will require MRI or operative evidence. Delayed-entry survival models will estimate the independent association of implant and surgical characteristics with rupture risk.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IQ interquirofanos

Medellín, Colombia

Location status: Recruiting

Location contact

juan Velez, MD, Plastic surgeon

CONTACT

+57 3054511588

About this study

Women with new or existing aesthetic silicone breast implants will enter the cohort only after baseline assessment confirms that the analyzed implant is intact. Implant and operative characteristics will be verified from device cards and operative records whenever possible. Annual high-resolution ultrasound will screen for integrity loss, with MRI or surgery used for confirmation under a standardized algorithm. Implant age will serve as the survival time scale, and prevalent implants will enter at their age on enrollment. The study will estimate rupture-free survival, symptomatic and silent rupture rates, adjusted predictor effects, and management after detection.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female sex and age 18 years or older.
  • Aesthetic breast augmentation with permanent silicone implants.
  • Known implantation date or sufficiently precise implantation year, pocket plane, incision route, surface texture, and implant volume.
  • Both implants or the analyzed implant documented as intact at baseline by the study imaging algorithm.
  • Ability to complete annual surveillance for up to five years.
  • Written informed consent.

Exclusion criteria

  • Reconstructive implantation after mastectomy, congenital deformity, or major trauma.
  • Tissue expander or nonpermanent device.
  • Confirmed rupture at cohort entry for the implant under analysis.
  • PIP implant or another recalled device if the final protocol elects to exclude it from etiologic modeling.
  • Missing core implant characteristics or implantation date.
  • Planned immediate explantation or exchange at enrollment for a reason unrelated to surveillance.

Treatment and study plan

Silicone Breast Implant Exposure

Device

Implant-level exposure data include implantation date, laterality, pocket plane, incision route, surface texture, shape, volume, manufacturer/lot when available, primary versus revision placement, and concomitant mastopexy or fat grafting. Linked arm/group(s): Intact Aesthetic Breast Implant Surveillance Cohort.

Prospective Breast Implant Surveillance Imaging

Diagnostic Test

Baseline and annual high-resolution ultrasound will assess implant integrity. Suspicious or indeterminate findings will undergo MRI according to the locked diagnostic algorithm. Rupture is confirmed by MRI, operative inspection, or both. Linked arm/group(s): Intact Aesthetic Breast Implant Surveillance Cohort.

Primary outcomes

  1. Time to First Confirmed Breast Implant Rupture

    Time frame: From cohort entry through years of prospective follow-up. 10 TO 12 YEARS

    Implant-level time from cohort entry to the first MRI- or surgically confirmed full-thickness implant shell rupture. Implant age is used as the survival time scale with delayed entry at age on enrollment. Contralateral implants are accounted for by patient-level clustering.

Secondary outcomes

  1. Rupture-Free Survival by Implant Age

    Time frame: 12 YEARS

    Kaplan-Meier or model-based probability of remaining free of confirmed rupture at prespecified implant ages, using delayed-entry methods.

Study contacts

Contact information is provided by the study sponsor or research team.

Juan Velez, MD, Plastic surgeon

CONTACT

[email protected]

+57 3054511588

Sponsors and collaborators

Lead sponsor

Research Inc

Industry

Registry information

Important dates

Study start
2014
Primary completion
2026
Study completion
2026
First posted
Sep 9, 2026
Registry last updated
Sep 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.